Notice OF AGM IS ENCLOSED
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has filed the notice for its 42nd Annual General Meeting (AGM) to be held on 09th September 2025 at 12:00 noon via video conferencing, along with the Annual Report for FY 2024-25. The company reported revenue of about ₹370 crore and net profit of nearly ₹40 crore during the year, selling in over 80 countries with regulatory approvals from EU-GMP, SFDA, INVIMA, and ANVISA. Shareholders will vote on adopting the audited financial statements, re-appointing directors (Ramesh Arora as MD, Ajay Kumar Arora, Anju Arora, and Geeta Arora as Whole-Time Directors), appointing Vinod Kumar Sharma as a new Independent Director, and re-appointing Kartik Kapur as Independent Director for another five-year term. M/s Rishi Mittal & Associates is proposed as Secretarial Auditor for five years, and the cost auditor's remuneration of ₹1,10,000 is being ratified. E-voting through NSDL runs from 06th to 08th September 2025, with the cut-off date being 01st September 2025.
Routine AGM filing with no unexpected corporate action; key watchpoints for shareholders are the proposed re-appointments of all promoter-family directors and their monthly remuneration (₹7 lakh for the MD, ₹7 lakh for Ajay Kumar Arora, and ₹3 lakh each for Anju and Geeta Arora). Investors should review the MD&A and audited financials in the annual report for the growth picture in oncology, biosimilars (erythropoietin expected to commercialise this fiscal), and regulated markets before voting.